Research Article | Volume: 6, Issue: 4, April, 2016
Research Article | Volume: 6, Issue: 4, April, 2016
An easily, specific, precise, and accurate reversed-phase HPLC method was developed and validated for simultaneous estimation of esomeprazole ( Nexium®) and tadalafil (Cialis®) in pharmaceutical formulation. The separation was achieved by using Hypersil BDS C18 column (250 mm × 4.6 mm; 5.0 μm) and acetonitrile: 0.05 M potassium dihydrogen phosphate buffer at pH 6 adjusted with phosphoric acid as a mobile phase at a flow rate of 1 mL/min. Detection was carried out at wavelength 285nm. The retention time of esomeprazole and tadalafil were 3.1, 3.7 min, respectively. The linearity was established over the concentration ranges of 60-180μg/mL and 40-120μg/mL with correlation coefficients 0.9998 and 0.9996 for esomeprazole and tadalafil, respectively. The mean recoveries were found to be in the ranges of 98–102% for esomeprazole and tadalafil. The proposed method has been validated as per ICH guidelines and successfully applied to the simultaneous estimation of esomeprazole and tadalafil in pharmaceutical formulation.
Hamad M, Al-Sharqawi A, Dayyih WA, Mallah E, Arafat T. Simultaneous estimation of Esomeprazole and Tadalafil in pharmaceutical formulationsusing High Performance Liquid Chromatography. J App Pharm Sci, 2016; 6 (04): 052-059.
Year
Month
Enteric coated tablets of novel proton pump inhibitor with super disintegrants design, in-vitro evaluation and stability studies
Putta Rajesh Kumar, Hiremath Doddayya, S. Rajendra ReddyA validated stability indicating HPLC method for the determination of Valsartan in tablet dosage forms
RP-HPLC-PDA method development and validation for the analysis of Tadalafil in bulk, pharmaceutical dosage forms and in-vitro dissolution samples
Development and validation of dissolution procedures
Bhavesh Vaghela, Rajan Kayastha, Nayana Bhatt, Nimish Pathak, Dashrath Rathod